Jonas M. Den Heijer

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Reply to the Letter to the Editor: Stefani A, "Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History".

Reply to the Letter to the Editor: Stefani A, "Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History".

Journal: Journal of Parkinson's disease

Published: March 08, 2024

The Etiology of Parkinson's Disease: New Perspectives from Gene-Environment Interactions.

The Etiology of Parkinson's Disease: New Perspectives from Gene-Environment Interactions.

Journal: Journal of Parkinson's disease

Published: November 19, 2023

A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.

A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 25, 2022

A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease.

A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease.

Journal: Movement disorders clinical practice

Published: August 10, 2022

Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patients.

Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patients.

Journal: Parkinsonism & related disorders

Published: October 22, 2021

A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator.

A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: October 10, 2021

A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009.

A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: October 01, 2021

Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a Subgroup.

Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a Subgroup.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 23, 2021

Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines.

Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines.

Journal: British journal of clinical pharmacology

Published: January 04, 2021

Brain Bio-Energetic State Does Not Correlate to Muscle Mitochondrial Function in Huntington's Disease.

Brain Bio-Energetic State Does Not Correlate to Muscle Mitochondrial Function in Huntington's Disease.

Journal: Journal of Huntington's disease

Published: December 16, 2020

False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance.

False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance.

Journal: Scientific reports

Published: October 26, 2020

A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator.

A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator.

Journal: British journal of clinical pharmacology

Published: August 20, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026